Mechanisms of cell sensitization to alpha radioimmunotherapy by doxorubicin or paclitaxel in multiple myeloma cell lines. [electronic resource]
Producer: 20060223Description: 7047s-7052s p. digitalISSN:- 1078-0432
- Antibiotics, Antineoplastic -- pharmacology
- Antibodies, Monoclonal -- chemistry
- Antineoplastic Agents, Phytogenic -- pharmacology
- Apoptosis
- Cell Cycle
- Cell Division
- Cell Line, Tumor
- Cell Survival
- Combined Modality Therapy
- Comet Assay
- DNA Damage
- Dose-Response Relationship, Drug
- Doxorubicin -- pharmacology
- G2 Phase
- Humans
- Image Processing, Computer-Assisted
- Multiple Myeloma -- drug therapy
- Paclitaxel -- pharmacology
- Radiation Tolerance
- Radioimmunotherapy -- methods
- Radioisotopes -- metabolism
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.